Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination
GMS Hygiene and Infection Control · 07.09.2023 · 18 (Doc20) · Doc20
DOI: 10.3205/dgkh000446 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 07.09.2023. Verfasst von Reyhaneh Alipoor Rafie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shahid Beheshti University of Medical sciences, Tehran, Iran. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Studies in different communities have shown significant differences in IgG antibody titers in the time period after the first and second doses of the vaccines. This study aimed to serologically evaluate the IgG anti-spike antibody titer five months after injection of the second COVID-19 vaccine in healthcare workers. Materials and method: This study was performed in healthcare personnel for whom five months had passed since their second anti-Covid-19 vaccination. The level of IgG antibody against SARS-CoV-2 spike protein was measured by ELISA. Healthcare workers in Mofid Children’s hospital received three brands of vaccines: Sputnik V, Sinopharm, and AstraZeneca.
Results
The mean titer of anti-spike IgG was 4.3±2.29 units. The percentage of positive cases of the antibody was estimated to be 96.4%. The titer of anti-spike IgG antibody was dependent on both the occupational area and a positive history of Covid-19 disease.
Conclusion
About 96.4% of the staff vaccinated against Covid-19 had a high titer of anti-spike IgG antibody even five months after inoculation of the second dose. The field of occupational can affect the level of antibody present
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Shahid Beheshti University of Medical sciences, Tehran, Iran.
- Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Rafie, R. A., Azimi, L., Armin, S., Aghamohammadi, A., Karimi, A., Fallah, F., Khodaei, H., Mansour Ghanaie, R., & Alebouyeh, M. (2023). Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination. GMS Hygiene and Infection Control, 18(Doc20), Doc20. https://doi.org/10.3205/dgkh000446
Vancouver
Rafie RA, Azimi L, Armin S, Aghamohammadi A, Karimi A, Fallah F, et al. Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination. GMS Hygiene and Infection Control. 2023;18(Doc20):Doc20. doi:10.3205/dgkh000446
BibTeX
@article{Rafie2023,
author = {Rafie, Reyhaneh Alipoor and Azimi, Leila and Armin, Shahnaz and Aghamohammadi, Amirali and Karimi, Abdollah and Fallah, Fatemeh and Khodaei, Hannan and Mansour Ghanaie, Roxana and Alebouyeh, Masoud},
title = {Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination},
journal = {GMS Hygiene and Infection Control},
year = {2023},
volume = {18},
number = {Doc20},
pages = {Doc20},
doi = {10.3205/dgkh000446}
}
EUVIMED